Form 4 for FBIO Fortress Biotech, Inc.
Accepted 2022-04-29 00:00:00 ET · period of report 2021-08-05 · accession 0001104659-22-053625 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-04-29 | 2021-08-05+ | FBIO | Klein Dov | Dir | J - Other | $0.00 | +1,015 | 655.8K | +0.2% | $0 |
| 2022-04-29 | 2021-12-28 | FBIO | Klein Dov | Dir | S - Sale | $2.45 | -5,000 | 651.0K | -0.8% | -$12.2K | |
| 2022-04-29 | 2022-01-01 | FBIO | Klein Dov | Dir | A - Grant | $0.00 | +100.0K | 751.0K | +15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.001 | 2021-08-05 | J | A | 305 | $0.00 | 655,305 | D | — | — | (F2) The total holdings include 480,000 shares of deferred restricted stock and 40,000 shares underlying deferred restricted stock units. |
| 2 | Common | Common Stock, par value $0.001 | 2021-12-28 | S | D | 5,000 | $2.45 | 651,015 | D | — | — | (F2) The total holdings include 480,000 shares of deferred restricted stock and 40,000 shares underlying deferred restricted stock units. |
| 3 | Common | Common Stock, par value $0.001 | 2021-11-16 | J | A | 230 | $0.00 | 656,015 | D | — | — | (F2) The total holdings include 480,000 shares of deferred restricted stock and 40,000 shares underlying deferred restricted stock units. |
| 4 | Common | Common Stock, par value $0.001 | 2022-01-01 | A | A | 100,000 | $0.00 | 751,015 | D | — | — | (F4) One-third of the shares will vest on each of January 1, 2023, 2024 and 2025, subject to continued service. The reporting person elected to defer 80,000 of these restricted shares pursuant to the issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the reporting person in January of the year following the reporting person's termination of service, or earlier upon his death or change in control of the issuer. (F5) The total holdings include 560,000 shares of deferred restricted stock and 40,000 shares underlying deferred restricted stock units. |
| 5 | Common | Common Stock, par value $0.001 | 2021-09-30 | J | A | 480 | $0.00 | 655,785 | D | — | — | (F2) The total holdings include 480,000 shares of deferred restricted stock and 40,000 shares underlying deferred restricted stock units. |